1 |
imiquimod
(545 times)
|
Pharmacology (102 times)
|
IL (64 times) PASI (56 times) DCs (25 times)
|
2004 Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro.
|
2 |
Infant/Child Monitoring Questionnaire
(4 times)
|
Pediatrics (3 times)
|
BioT (1 time) GMDS (1 time) NE (1 time)
|
1996 Do parents and professionals agree on the developmental status of high-risk infants?
|
3 |
imiquimod cream
(3 times)
|
Metabolism (1 time)
|
AS (1 time) Cal (1 time) cDCs (1 time)
|
2016 Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.
|
4 |
imquimod
(2 times)
|
Chemistry, Pharmaceutical (1 time)
|
AD (1 time) PASI (1 time) TRIM (1 time)
|
2016 Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis.
|
5 |
inverse multiquadric
(2 times)
|
Environmental Health (1 time)
|
MQ (2 times) CRS (1 time) IDE (1 time)
|
2016 Analysis of cornea curvature using radial basis functions - Part I: Methodology.
|
6 |
illness management questionnaire
(1 time)
|
Health Services (1 time)
|
CFS (1 time)
|
1993 Ways of coping with chronic fatigue syndrome: development of an illness management questionnaire.
|
7 |
imazaquin
(1 time)
|
|
ALS (1 time) BPS (1 time) BSM (1 time)
|
2014 Characterization of sulfonylurea-resistant Schoenoplectus juncoides having a target-site Asp(376)Glu mutation in the acetolactate synthase.
|
8 |
imidazoquinoxaline
(1 time)
|
Panax (1 time)
|
BNP (1 time) ECG (1 time) GCLM (1 time)
|
2023 Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways.
|
9 |
imiquimod-induced psoriasis mouse
(1 time)
|
Immune System Diseases (1 time)
|
---
|
2021 Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
|
10 |
imizoquin
(1 time)
|
Chemistry (1 time)
|
AF (1 time) AL (1 time) qRT (1 time)
|
2022 Linolenic Acid-Derived Oxylipins Inhibit Aflatoxin Biosynthesis in Aspergillus flavus through Activation of Imizoquin Biosynthesis.
|
11 |
IMQ-treated
(1 time)
|
Vascular Diseases (1 time)
|
TLR7 (1 time)
|
2020 Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice.
|
12 |
in vivo mouse model of imiquimod
(1 time)
|
Complementary Therapies (1 time)
|
DGLHT (1 time)
|
2018 Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
|
13 |
Independent Mobility Questionnaire
(1 time)
|
Optometry (1 time)
|
---
|
2015 Rasch Analysis of the Independent Mobility Questionnaire.
|
14 |
interactive mentalization questionnaire
(1 time)
|
Cognitive Science (1 time)
|
---
|
2022 Mentalizing During Social Interaction: The Development and Validation of the Interactive Mentalizing Questionnaire.
|
15 |
Interpersonal Mindfulness Questionnaire
(1 time)
|
Mental Disorders (1 time)
|
---
|
2022 Interpersonal Mindfulness Questionnaire: Scale Development and Validation.
|
16 |
into mice with imiquimod
(1 time)
|
Cell Biology (1 time)
|
hUC-MSCs (1 time) MSCs (1 time)
|
2022 Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing gammadelta T cells.
|
17 |
intramuscular injection of quinine
(1 time)
|
Tropical Medicine (1 time)
|
IRQ (1 time)
|
2000 [Tolerance of quinine administered as an intrarectal solution in children in French-speaking Africa].
|
18 |
treatments-imiquimod
(1 time)
|
Ophthalmology (1 time)
|
BCC (1 time) RT (1 time)
|
2011 Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
|